ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2026
Concomitant Aortic Root Replacement in Total Arch Replacement With Frozen Elephant Trunk for Type A Aortic Dissection: A Propensity-Weighted Analysis.
Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Weighing the Risks: The Impact of Body Mass Index on Outcomes After Frozen Elephant Trunk Aortic Arch Repair.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesThis study aims to evaluate the impact of concomitant aortic root replacement (ARR) on early and late outcomes in patients undergoing total arch replacement (TAR) with frozen elephant trunk (FET) for type A aortic dissection (TAAD).
methodsFrom January 2010 to December 2019, a total of 1155 patients were enrolled. Among them, 325 patients received concomitant ARR (with ARR group) while 830 patients did not (without ARR group). Baseline differences were adjusted using inverse probability of treatment weighting (IPTW).
resultsAfter IPTW, the with ARR group still had a higher prevalence of Marfan syndrome (2.6% vs 7.3%, P = .038) and a greater proportion of patients with moderate or greater aortic insufficiency (18.1% vs 64.7%, P < .001). Cardiopulmonary bypass (CPB) time and aortic cross-clamp time were significantly longer in with ARR group (CPB time: 180 [151-212] vs 197 [171-236] min, P < .001; cross-clamp time: 100 [83-120] vs 112 [95-135] min, P < .001). There were no significant differences in 30-day mortality and major complications. Multivariable logistic regression analysis revealed that after adjustment for age, gender, variables with potential clinical correlation with outcomes and variables with P < .1 in univariable analysis, ARR was not associated with 30-day mortality (odds ratio [OR]: 0.92, 95% CI: 0.52-1.62, P = .769). There was no significant difference in overall survival (log rank: P = .258) and proximal reintervention (log rank: P = .337) in follow-up between patients in with ARR group and without ARR group.
conclusionsIn patients undergoing TAR with FET for TAAD, concomitant ARR did not increase early and late postoperative mortality or morbidity. ARR can be safely performed concurrently with TAR and FET when anatomically indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.